by Usha Govindarajulu | Oct 14, 2022 | Biostatistics, Blog, COVID-19, Healtcare
October 13, 2022 A recent article in JAMA, “Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes” focuses on looking at the association of COVID-19 vaccination and boosters or prior infection with...
by Usha Govindarajulu | Sep 30, 2022 | Biostatistics, Blog, COVID-19, Healtcare
September 26, 2022 A recent article in New Medical Life Sciences, “Researchers explore neurological manifestations among long COVID patients” focuses on an article that appeared in Nature Medicine regarding a published study on assessing long-term neurological...
by Usha Govindarajulu | Sep 14, 2022 | Biostatistics, Blog, COVID-19, Healtcare
September 14, 2022 According to a recent article in Nature Communications, regular rapid testing provided two-fold benefits: identifying infectious individuals and providing positive tests sufficiently early during infection that treatment with antivirals can...
by Usha Govindarajulu | Aug 31, 2022 | Biostatistics, Blog, COVID-19, Epidemiology, Healtcare, Usha Govindarajulu
August 31, 2022 In a recent article in NEJM that appeared this month, researchers conducted a double-blind randomized placebo-controlled trial of metformin, ivermectin, and fluvoxamine to study their effectiveness against outcomes related to COVID-19. They used a...
by Usha Govindarajulu | Aug 17, 2022 | Biostatistics, Blog, COVID-19, Healtcare, Usha Govindarajulu
August 17, 2022 In a recent article in Asthma and Allergy, Sohn et al discuss what the impacts were for patients with severe asthma who wore masks during the pandemic in South Korea. Patients in the study were recruited from 5 university hospitals in 3 different...